The spectrum of haemostatic characteristics of women with unexplained menorrhagia

Haemophilia

Volumn 17, Issue 1, 2011, Pages

  Miller, C H ^a   Philipp, C S ^b   Stein, S F ^c   Kouides, P A ^d   Lukes, A S ^e   Heit, J A ^f   Byams, V R ^a   Dowling, N F ^a   Kulkarni, R ^a,g  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e DUKE UNIVERSITY   (United States)

^f MAYO CLINIC   (United States)

^g MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Bleeding disorders; Menorrhagia; Platelet function disorders; Von Willebrand disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PLASMINOGEN ACTIVATOR; PROTHROMBIN;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; BLOOD CLOTTING PARAMETERS; CAUCASIAN; CONTROLLED STUDY; FEMALE; FUNCTION TEST; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL CYCLE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; UNITED STATES; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD PLATELET DISORDERS; FEMALE; HUMANS; MENORRHAGIA; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 79951916912     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02382.x     Document Type: Article

References (23)

1. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. Von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004; 111: 734-40.
2. Philipp CS, Dilley A, Miller CH et al. Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost 2003; 1: 477-84.
3. Kouides P, Byams VR, Philipp CS et al. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br J Haematol 2009; 145: 212-20.
4. Higham JM, O'Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-9.
5. Miller CH, Platt SJ, Daniele C, Kaczor D. Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand factor. Thromb Haemost 2002; 88: 56-9.
6. Dilley A, Drews C, Miller C et al. Von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 2001; 97: 630-6.
7. Miller CH, Dilley A, Richardson L, Hooper WC, Evatt BL. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J Hematol 2001; 67: 125-9.
8. Nichols WL, Hultin MB, James AH et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel Report (USA). Haemophilia 2008; 14: 171-232.
9. Bolton-Maggs PHB. Bleeding problems in factor XI deficient women. Haemophilia 1999; 5: 155-9.
10. Takahashi Y, Tanaka T, Minowa H et al. Hereditary partial deficiency of plasminogen activator inhibitor-1 associated with a lifelong bleeding tendency. Intern J Hematol 1996; 64: 61-8.
11. Hancock JF, Wieland K, Pugh RE et al. A molecular genetic study of factor XI deficiency. Blood 1991; 77: 1942-9.
12. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-52.
13. Acharya SS, Coughlin A, DiMichele DM, North American Rare Bleeding Disorder Study Group. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2: 248-56.
14. Moffat KA, Ledford-Kraemer MR, Nichols WL, Hayward CP. Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost 2005; 93: 549-53.
15. Bevan JA, Maloney KW, Hillery CA, Gill JC, Montgomery RR. Bleeding disorders: a common cause of menorrhagia in adolescents. J Pediatr 2001; 138: 856-61.
16. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170.
17. Stein SF, Rice A, Lindstrom K, Miller CH. Platelet aggregation and ATP release studies in drug-free normals demonstrate high false-positive rates with multiple instruments. J Thromb Haemost 2009; 7 (Suppl 2): PP-WE-749.
18. Hayward CPM, Pai M, Liu Y et al. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost 2009; 7: 676-84.
19. Arthur JF, Dunkley S, Andrews RK. Platelet glycoprotein VI-related clinical defects. Br J Haematol 2007; 139: 363-72.
20. Flood VH, Freidman KD, Gill JC et al. Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function. J Thromb Haemost 2009; 7: 1832-9.
21. Buchanan GR, Holtkamp CA, Levy EN. Racial differences in ristocetin-induced platelet aggregation. Br J Haematol 1981; 49: 455-64.
22. Quiroga T, Goyocoolea M, Panes O et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 2007; 92: 357-65.
23. Brandao LR, Briones M, Miller CH, White JG, Kauffman J, Abshire TC. Clinical and laboratory features of mild bleeding disorders (MBD) in children. J Thromb Haemost 2005; 3, (Suppl. 1): P0260.